Tumor Progression

4 registered clinical trials studyying Tumor Progression.

Status	Trial	Sponsor	Phase
Unknown	Predictive Value of Human Microbiome and Serological Markers for Clinical Outcome of AIS With Active Cancer NCT05553990	Nanfang Hospital, Southern Medical University	—
Completed	Optimal EGFR TKIs Treatment Strategies for Lung Adenocarcinoma Harboring EGFR Exon 19 Deletion Variants NCT04370860	National Taiwan University Hospital	—
Completed	The Role of Protein Tyrosine Kinase 7 (PTK7) in Non-small Cell Lung Cancer NCT04018183	National Taiwan University Hospital	—
Unknown	Sodium Selenite as a Cytotoxic Agent in Advanced Carcinoma NCT01959438	Karolinska University Hospital	Phase 1 / Phase 2